Literature DB >> 10591159

Differential secretion of interleukin-12 (IL-12) subunits and heterodimeric IL-12p70 protein by CD-1 mice and murine macrophages in response to intracellular infection by Brucella abortus.

Luis Fernández-Lago, Elisa Rodríguez-Tarazona, Nieves Vizcaíno.   

Abstract

The secretion of interleukin-12 (IL-12) following intracellular infection with virulent Brucella abortus strain 2308 was investigated in CD-1 mice and in CD-1 cultured peritoneal macrophages. Bioactive IL-12p70 and free non-immunoactive p40 subunits (IL-12p40) were determined by enzyme-linked immunosorbent assays. In CD-1 mice, B. abortus 2308 was a potent inducer of IL-12p40 (maximum levels were 5.9 and 3.4 ng/ml in sera and spleen homogenates, respectively). Secretion of IL-12p70 was also demonstrated in vivo, although at much lower levels (216.6 and 198.9 pg/ml in sera and spleen homogenates, respectively). Production of IL-12 over the first 7 days after infection was accompanied by active multiplication of B. abortus in the spleens of infected mice. CD-1 cultured peritoneal macrophages secreted only IL-12p40 (878.4 pg/10(7) macrophages) in response to B. abortus infection and no production of IL-12p70 was observed. In contrast, CD-1 peritoneal macrophages secreted detectable amounts of IL-12p70 (16.2 pg/10(7) macrophages) in response to purified lipopolysaccharide (S-LPS) from B. abortus 2308. The macrophages also secreted significant amounts of interferon-gamma (IFN-gamma) (520.1 pg/10(7) macrophages) in response to intracellular B. abortus. These results indicate that B. abortus 2308 is not a potent inducer of IL-12p70 production, whereas purified S-LPS from B. abortus 2308 induces the secretion of this bioactive form of IL-12 in cultured peritoneal macrophages. CD-1 peritoneal macrophages were able to secrete IFN-gamma, as well as high amounts of IL-12p40, in response to intracellular infection by B. abortus.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10591159     DOI: 10.1099/00222615-48-12-1065

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  7 in total

1.  Mouse cytokine profiles associated with Brucella abortus RB51 vaccination or B. abortus 2308 infection.

Authors:  P Pasquali; R Adone; L C Gasbarre; C Pistoia; F Ciuchini
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

2.  Effects of exogenous recombinant interleukin-12 on immune responses and protection against Brucella abortus in a murine model.

Authors:  I K Lee; S C Olsen; C A Bolin
Journal:  Can J Vet Res       Date:  2001-10       Impact factor: 1.310

3.  Inactivation of the type IV secretion system reduces the Th1 polarization of the immune response to Brucella abortus infection.

Authors:  Hortensia García Rolán; Renée M Tsolis
Journal:  Infect Immun       Date:  2008-05-05       Impact factor: 3.441

4.  Key role of Toll-like receptor 2 in the inflammatory response and major histocompatibility complex class ii downregulation in Brucella abortus-infected alveolar macrophages.

Authors:  Mariana C Ferrero; M Soledad Hielpos; Natalia B Carvalho; Paula Barrionuevo; Patricia P Corsetti; Guillermo H Giambartolomei; Sergio C Oliveira; Pablo C Baldi
Journal:  Infect Immun       Date:  2013-11-25       Impact factor: 3.441

Review 5.  What have we learned from brucellosis in the mouse model?

Authors:  María-Jesús Grilló; José María Blasco; Jean Pierre Gorvel; Ignacio Moriyón; Edgardo Moreno
Journal:  Vet Res       Date:  2012-04-13       Impact factor: 3.683

6.  Host interferon-γ inducible protein contributes to Brucella survival.

Authors:  Jennifer A Ritchie; Adam Rupper; James A Cardelli; Bryan H Bellaire
Journal:  Front Cell Infect Microbiol       Date:  2012-04-27       Impact factor: 5.293

7.  Evaluation in mice of Brucella ovis attenuated mutants for use as live vaccines against B. ovis infection.

Authors:  Pilar Sancho; Carmen Tejedor; Rebeca S Sidhu-Muñoz; Luis Fernández-Lago; Nieves Vizcaíno
Journal:  Vet Res       Date:  2014-06-04       Impact factor: 3.683

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.